When and how do patients with cardiac amyloidosis die?

ConclusionOur data indicate no differences in MOD between patients with AL and ATTRwt cardiac amyloidosis despite significant differences in clinical presentation and disease progression. Cardiovascular events account for more than two-thirds of fatal casualties in both groups.Graphic abstract

http://link.springer.com/10.1007/s00392-019-01490-2

Source: Clinical Research in Cardiology - May 26, 2019 Category: Cardiology Source Type: research